Terms: = Endocrine gland cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
41 results:
1. Nuclear MAST4 Suppresses foxo3 through Interaction with AKT3 and Induces Chemoresistance in Pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
2. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract] [Full Text] [Related]
3. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH; Al-Hallak MN; Khan HY; Aboukameel A; Li Y; Bannoura SF; Dyson G; Kim S; Mzannar Y; Azar I; Odisho T; Mohamed A; Landesman Y; Kim S; Beydoun R; Mohammad RM; Philip PA; Shields AF; Azmi AS
Clin Transl Med; 2023 Dec; 13(12):e1513. PubMed ID: 38131168
[TBL] [Abstract] [Full Text] [Related]
4. Prolyl isomerase Pin1 promotes autophagy and cancer cell viability through activating foxo3 signalling.
Long J; Wang J; Dong Y; Yang J; Xie G; Tong Y
Cell Signal; 2024 Jan; 113():110940. PubMed ID: 38084839
[TBL] [Abstract] [Full Text] [Related]
5. Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of foxo3A.
Zhang Z; Zhang Q; Yu Y; Su S
In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):739-746. PubMed ID: 38038884
[TBL] [Abstract] [Full Text] [Related]
6. Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian cancer and by Regulation of the IL-6/STAT3/foxo3a Pathway.
Park SA; Seo YJ; Kim LK; Kim HJ; Yoon KD; Heo TH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047012
[No Abstract] [Full Text] [Related]
7. Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications.
Li Y; He Y; Chen Y; He Z; Yang F; Xing C
Apoptosis; 2023 Apr; 28(3-4):576-593. PubMed ID: 36695983
[TBL] [Abstract] [Full Text] [Related]
8. An
Lee CM; Kang MA; Bae JS; Park K; Yang YH; Lee J; Jang KY; Park SH
Hum Exp Toxicol; 2022; 41():9603271221089257. PubMed ID: 35417658
[TBL] [Abstract] [Full Text] [Related]
9. RBM47/SNHG5/foxo3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Lv C; Zhang H
Cell Death Dis; 2022 Mar; 13(3):270. PubMed ID: 35338124
[TBL] [Abstract] [Full Text] [Related]
10. LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/foxo3/BID axis to inhibit the progression of pancreatic cancer.
Bi C; Wang G
J Cell Mol Med; 2021 Sep; 25(17):8312-8328. PubMed ID: 34363438
[TBL] [Abstract] [Full Text] [Related]
11. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract] [Full Text] [Related]
12. Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/foxo3 pathway.
Huo Q; Xu C; Shao Y; Yu Q; Huang L; Liu Y; Bao H
Int J Biol Sci; 2021; 17(2):574-588. PubMed ID: 33613114
[No Abstract] [Full Text] [Related]
13. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/foxo3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract] [Full Text] [Related]
14. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
15. Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low-dose fraction radiation.
Zhao L; Liu S; Liang D; Jiang T; Yan X; Zhao S; Liu Y; Zhao W; Yu H
Cancer Med; 2019 May; 8(5):2442-2448. PubMed ID: 30941896
[TBL] [Abstract] [Full Text] [Related]
16. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
Mao W; Peters HL; Sutton MN; Orozco AF; Pang L; Yang H; Lu Z; Bast RC
Cancer; 2019 Apr; 125(8):1267-1280. PubMed ID: 30620384
[TBL] [Abstract] [Full Text] [Related]
17. HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/foxo3 signaling pathway.
Yao Y; Zhou L; Liao W; Chen H; Du Z; Shao C; Wang P; Ding K
Carbohydr Polym; 2019 Jan; 204():111-123. PubMed ID: 30366522
[TBL] [Abstract] [Full Text] [Related]
18. foxo3a Reverses the Cisplatin Resistance in Ovarian cancer.
Lu M; Chen X; Xiao J; Xiang J; Yang L; Chen D
Arch Med Res; 2018 Feb; 49(2):84-88. PubMed ID: 29716743
[TBL] [Abstract] [Full Text] [Related]
19. Propofol Prevents the Progression of Malignant Pheochromocytoma In Vitro and In Vivo.
Wang H; Zhang S; Zhang A; Yan C
DNA Cell Biol; 2018 Apr; 37(4):308-315. PubMed ID: 29565198
[TBL] [Abstract] [Full Text] [Related]
20. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract] [Full Text] [Related]
[Next]
